Nitrogen Balance in Infants After Post Cardiothoracic Surgery
Determination of Protein Needs Using Nitrogen Balance in Infants Immediately Post Cardiothoracic Surgery
1 other identifier
interventional
24
1 country
1
Brief Summary
The objective is to the amount of protein infants require after cardiopulmonary bypass surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Aug 2009
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 6, 2011
CompletedFirst Posted
Study publicly available on registry
June 8, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedAugust 19, 2013
August 1, 2013
2.8 years
June 6, 2011
August 16, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nitrogen Balance
After an initial adaptation period of approximately 12 hours receiving parenteral nutrition the first 24-hour urine collection for nitrogen balance will be started; following this two successive 24-hour urine collections will be performed in order to obtain a three-day collection for nitrogen balance analyses.
From 0-84 hours
Study Arms (3)
Control Group
ACTIVE COMPARATORIntervention Group 1
EXPERIMENTALIntervention Group 2
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Clinical decision to initiate parenteral nutrition based on determination by medical team
- Gestational age ≥ 35 weeks
- Birth weight ≥ 2000 grams
- Indwelling urinary catheters for urine collection
- Central venous access for parenteral nutrition
You may not qualify if:
- Chromosomal abnormalities known to effect protein metabolism
- Hepatic failure defined as ALT and AST \> 500 UL with an INR \> 2.5, not accounted for by therapeutic anticoagulation
- Renal failure defined as creatinine 2x the upper limit of normal for age.
- Sepsis or suspected sepsis, defined as clinical suspicion or confirmation of a systemic infection treated with antibiotics
- Excessive blood loss from chest tubes (5 ml/kg/hr) that has not resolved within six hours following admission to the CCCU; as indicated by the need for frequent blood transfusion these subjects will be withdrawn from the study
- Requiring Extra Corporeal Membrane Oxygenation (ECMO) support
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hospital for Sick Children
Toronto, Ontario, M5V 1B2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul B Pencharz, MD
The Hospital for Sick Children, Toronto, Canada
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Emeritus Scientist
Study Record Dates
First Submitted
June 6, 2011
First Posted
June 8, 2011
Study Start
August 1, 2009
Primary Completion
June 1, 2012
Study Completion
June 1, 2012
Last Updated
August 19, 2013
Record last verified: 2013-08